1. Home
  2. NTRA vs AFRM Comparison

NTRA vs AFRM Comparison

Compare NTRA & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • AFRM
  • Stock Information
  • Founded
  • NTRA 2003
  • AFRM 2012
  • Country
  • NTRA United States
  • AFRM United States
  • Employees
  • NTRA N/A
  • AFRM N/A
  • Industry
  • NTRA Medical Specialities
  • AFRM Business Services
  • Sector
  • NTRA Health Care
  • AFRM Consumer Discretionary
  • Exchange
  • NTRA Nasdaq
  • AFRM Nasdaq
  • Market Cap
  • NTRA 22.1B
  • AFRM 24.8B
  • IPO Year
  • NTRA 2015
  • AFRM 2021
  • Fundamental
  • Price
  • NTRA $162.31
  • AFRM $68.55
  • Analyst Decision
  • NTRA Strong Buy
  • AFRM Buy
  • Analyst Count
  • NTRA 17
  • AFRM 19
  • Target Price
  • NTRA $165.88
  • AFRM $70.24
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • AFRM 7.8M
  • Earning Date
  • NTRA 02-27-2025
  • AFRM 02-06-2025
  • Dividend Yield
  • NTRA N/A
  • AFRM N/A
  • EPS Growth
  • NTRA N/A
  • AFRM N/A
  • EPS
  • NTRA N/A
  • AFRM N/A
  • Revenue
  • NTRA $1,531,955,000.00
  • AFRM $2,800,203,000.00
  • Revenue This Year
  • NTRA $56.11
  • AFRM $35.82
  • Revenue Next Year
  • NTRA $9.76
  • AFRM $23.07
  • P/E Ratio
  • NTRA N/A
  • AFRM N/A
  • Revenue Growth
  • NTRA 54.94
  • AFRM 46.27
  • 52 Week Low
  • NTRA $69.91
  • AFRM $22.25
  • 52 Week High
  • NTRA $183.00
  • AFRM $82.53
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 40.88
  • AFRM 49.87
  • Support Level
  • NTRA $168.15
  • AFRM $74.50
  • Resistance Level
  • NTRA $180.41
  • AFRM $82.53
  • Average True Range (ATR)
  • NTRA 7.08
  • AFRM 4.37
  • MACD
  • NTRA -1.24
  • AFRM 0.27
  • Stochastic Oscillator
  • NTRA 14.58
  • AFRM 45.74

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About AFRM Affirm Holdings Inc.

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

Share on Social Networks: